Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia)
暂无分享,去创建一个
M. Beckmann | L. Häberle | A. Hein | J. Lelieveld | H. Schneider | V. Hanf | C. Tiemann | M. Rübner | F. Faschingbauer | M. Schrauder | P. Fasching | F. Kainer | Lena A. Wurmthaler | Michael O. Schneider | M. Koch | U. Dammer | S. Kehl | F. Stumpfe | A. Hartmann | Carolin Kladt | Rebecca Peuker | Denise Mereutanu | Kirstin Meyer-Schlinkmann | Hanna Philipp | Stefan Weingärtler
[1] M. Rüdiger,et al. Neonatal outcome following maternal infection with SARS-CoV-2 in Germany: COVID-19-Related Obstetric and Neonatal Outcome Study (CRONOS) , 2021, Archives of Disease in Childhood.
[2] A. Papageorghiou,et al. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection , 2021, JAMA pediatrics.
[3] M. Baldini,et al. Universal SARS-CoV-2 screening in pregnant women: experience from the Italian epidemic outbreak , 2021, Acta bio-medica : Atenei Parmensis.
[4] Ravindra K. Gupta,et al. Samba II PCR testing for COVID-19 in pregnant women: a retrospective cohort study and literature review , 2021, BMC Pregnancy and Childbirth.
[5] J. Pum,et al. Analysis of cycle threshold values in SARS-CoV-2-PCR in a long-term study , 2021, Journal of Clinical Virology.
[6] F. Pérez-López,et al. Screening of severe acute respiratory syndrome coronavirus-2 infection during labor and delivery using polymerase chain reaction and immunoglobulin testing , 2021, Life Sciences.
[7] S. Solomon,et al. Clinical Characteristics and Outcomes of Hospitalized Women Giving Birth With and Without COVID-19. , 2021, JAMA internal medicine.
[8] T. Issat,et al. No COVID-19 Cases Detected Between April and September 2020 After Screening All 838 Admissions to a Maternity Unit in Poland , 2020, Medical science monitor : international medical journal of experimental and clinical research.
[9] M. Rüdiger,et al. Pregnancy and SARS-CoV-2 Infection in Germany-the CRONOS Registry. , 2020, Deutsches Arzteblatt international.
[10] M. Nöthen,et al. Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany , 2020, Nature Communications.
[11] E. Draper,et al. Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK: a prospective national cohort study using active surveillance , 2020, The Lancet Child & Adolescent Health.
[12] E. Olsen,et al. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[13] E. Olsen,et al. Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy — SET-NET, 16 Jurisdictions, March 29–October 14, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[14] A. Benachi,et al. Synthesis and systematic review of reported neonatal SARS-CoV-2 infections , 2020, Nature Communications.
[15] M. Gismondo,et al. Analysis of SARS-CoV-2 vertical transmission during pregnancy , 2020, Nature Communications.
[16] J. Nien,et al. Routine screening for SARS CoV-2 in unselected pregnant women at delivery , 2020, PloS one.
[17] S. McLafferty,et al. Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 — COVID-NET, 13 States, March 1–August 22, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[18] Stephan Borrmann,et al. Aerosol transmission of COVID-19 and infection risk in indoor environments , 2020, medRxiv.
[19] Ephrem Awulachew,et al. The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal–fetal transmission: a systematic review and meta-analysis , 2020, European Journal of Medical Research.
[20] L. Mofenson,et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis , 2020, BMJ.
[21] T. Yeo,et al. Viral dynamics and immune correlates of COVID-19 disease severity , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] F. Gorlero,et al. Asymptomatic SARS‐CoV‐2 infections in pregnant patients in an Italian city during the complete lockdown , 2020, Journal of medical virology.
[23] J. Masci,et al. Universal screening for SARS-CoV-2 infection among pregnant women at Elmhurst Hospital Center, Queens, New York , 2020, medRxiv.
[24] M. Giles,et al. COVID‐19 and pregnancy: A review of clinical characteristics, obstetric outcomes and vertical transmission , 2020, The Australian & New Zealand journal of obstetrics & gynaecology.
[25] U. Pecks,et al. Perinatale Aspekte der SARS-CoV-2 Infektion , 2020, Zeitschrift für Geburtshilfe und Neonatologie.
[26] K. Hecher,et al. [Update on Recommendations for SARS-CoV-2/COVID-19 During Pregnancy, Birth and Childbed]. , 2020, Zeitschrift fur Geburtshilfe und Neonatologie.
[27] A. Scherag,et al. [Period Prevalence of SARS-CoV-2 in an Unselected Sample of Pregnant Women in Jena, Thuringia]. , 2020, Zeitschrift fur Geburtshilfe und Neonatologie.
[28] S. Unlu,et al. The rate of SARS-CoV-2 positivity in asymptomatic pregnant women admitted to hospital for delivery: Experience of a pandemic center in Turkey , 2020, European Journal of Obstetrics & Gynecology and Reproductive Biology.
[29] Lingkong Zeng,et al. Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 From the Mother to the Infant-Reply. , 2020, JAMA pediatrics.
[30] I. Burd,et al. COVID‐19 in pregnancy: Placental and neonatal involvement , 2020, American journal of reproductive immunology.
[31] G. Sotgiu,et al. COVID-19 in pregnant women: A systematic review and meta-analysis , 2020, European Journal of Obstetrics & Gynecology and Reproductive Biology.
[32] H. Honest,et al. Maternal COVID-19 infection, clinical characteristics, pregnancy, and neonatal outcome: A prospective cohort study , 2020, European Journal of Obstetrics & Gynecology and Reproductive Biology.
[33] D. Skupski,et al. Pregnancy and postpartum outcomes in a universally tested population for SARS‐CoV‐2 in New York City: a prospective cohort study , 2020, BJOG : an international journal of obstetrics and gynaecology.
[34] L. Magee,et al. SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy outcomes , 2020, EClinicalMedicine.
[35] S. Gilboa,et al. Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–June 7, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[36] Zunyou Wu,et al. Asymptomatic and Pre-Symptomatic COVID-19 in China , 2020, Infectious Diseases of Poverty.
[37] J. Dorling,et al. Maternal transmission of SARS‐COV‐2 to the neonate, and possible routes for such transmission: a systematic review and critical analysis , 2020, BJOG : an international journal of obstetrics and gynaecology.
[38] P. Brocklehurst,et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study , 2020, BMJ.
[39] A. Peaceman,et al. Clinical Implications of Universal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Testing in Pregnancy. , 2020, Obstetrics and gynecology.
[40] A. Khalil,et al. COVID-19 screening of health-care workers in a London maternity hospital , 2020, The Lancet Infectious Diseases.
[41] M. Arosio,et al. Vertical transmission of coronavirus disease 2019: severe acute respiratory syndrome coronavirus 2 RNA on the fetal side of the placenta in pregnancies with coronavirus disease 2019–positive mothers and neonates at birth , 2020, American Journal of Obstetrics & Gynecology Mfm.
[42] M. Arosio,et al. Vertical transmission of COVID-19: SARS-CoV-2 RNA on the fetal side of the placenta in pregnancies with COVID-19 positive mothers and neonates at birth , 2020, American Journal of Obstetrics & Gynecology MFM.
[43] A. Khalil,et al. Severe acute respiratory syndrome coronavirus 2 in pregnancy: symptomatic pregnant women are only the tip of the iceberg , 2020, American Journal of Obstetrics and Gynecology.
[44] M. Haghshenas,et al. Preterm delivery, maternal death, and vertical transmission in a pregnant woman with COVID‐19 infection , 2020, Prenatal Diagnosis.
[45] Dena Goffman,et al. Universal Screening for SARS-CoV-2 in Women Admitted for Delivery , 2020, The New England journal of medicine.
[46] Jian Wang,et al. Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn. , 2020, JAMA.
[47] M. Beckmann,et al. SARS-CoV-2 Infection in Pregnancy – a Review of the Current Literature and Possible Impact on Maternal and Neonatal Outcome , 2020, Geburtshilfe und Frauenheilkunde.
[48] Zunyou Wu,et al. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.
[49] E. Holmes,et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.
[50] Victor M Corman,et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[51] H. Melchior,et al. The Prevalence of Gestational Diabetes. , 2017, Deutsches Arzteblatt international.
[52] B. Gladen,et al. Estimating prevalence from the results of a screening test. , 1978, American journal of epidemiology.